Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence.

@article{Young2009PotentialBO,
  title={Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence.},
  author={Robert Peter Young and Raewyn Janice Hopkins and Tam E Eaton},
  journal={Postgraduate medical journal},
  year={2009},
  volume={85 1006},
  pages={414-21}
}
Studies show reduced forced expiratory volume in 1 s (FEV(1)) in patients with chronic obstructive pulmonary disease (COPD) is an important independent predictor of cardiovascular death and is characterised by both pulmonary and systemic inflammation. Evidence shows statins have important anti-inflammatory effects in both the lungs and arteries. Although randomised control trials are yet to be reported, non-randomised studies have consistently shown benefit in COPD patients taking statins… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

European respiratory review : an official journal of the European Respiratory Society • 2015

References

Publications referenced by this paper.
Showing 1-10 of 98 references

The association between statins and cancer incidence in a veterans population.

Journal of the National Cancer Institute • 2008
View 3 Excerpts
Highly Influenced

Association of radiographic emphysema and airflow limitation with lung cancer

DO Wilson, JL Weissfeld, A Balkan
Am Respir Crit Care Med • 2008

C-reactive protein levels and survival in patients with moderate to very severe COPD

JP de Torres, V Pinto-Plata, C Casanova
Chest • 2008

Chronic obstructive pulmonary disease with lung cancer and / or cardiovascular disease

R Rodriguz-Roisin, JB Soriano
Proc Am Thorac Soc • 2008

Similar Papers

Loading similar papers…